Companies /Healthcare

Twist Bioscience Corp

NASDAQ: TWST Diagnostics & Research
$153.10
â–² $3.04 (+2.03%) today
Markets closed · 9:02pm ET
Today · % change

Fundamentals

Market Cap
$9.4B
Profit Margin
-31.7%
Revenue (TTM)
$431.8M
EPS (TTM)
$-2.21
52-Week Range
$23 – $155
Street Target
$105.30

About Twist Bioscience

Twist Bioscience Corp is at the forefront of synthetic DNA technology, offering a wide range of products and services. These include synthetic genes, gene fragments, and immunoglobulin G proteins for various sectors like therapeutics, diagnostics, and agriculture. The company also specializes in next-generation sequencing (NGS) tools, methylation detection kits, and DNA-based data storage solutions. Additionally, Twist Bioscience provides vital resources for drug discovery and development, including precision DNA libraries and antibody optimization solutions. Founded in 2013, its headquarters are in South San Francisco, California, marking it as a key player in biotech innovation.

TWST Coverage

11:53am ET
Investing

TWST vs. NTRA: Which Genomics Play Is a Better Buy?

Cathie Wood’s Ark funds have been really heating up in recent months. Perhaps her most intriguing and underrated fund is the Ark Genomics Revolution ETF (ARKG), which is packed full of extraordinary…

Joey Frenette
9:29am ET
Investing

1 Top Technology ETF to Buy and 1 to Avoid

The technology-oriented Nasdaq 100 index is back into correction territory, down 10.5% after hitting an all-time high last month. The tech sector has been the driving force for the stock market’s gains…

Rich Duprey